Sycamore Partners to Privatize Walgreens Boots Alliance
Sycamore agreed to acquire Walgreens Boots Alliance (WBA), the century-old pharmacy and retail chain, in a leveraged deal worth approximately USD 23.7 billion, including debt.
Sycamore Partners’ landmark acquisition of WBA—advised by Latham & Watkins—has global implications, but could there be ripples in Israel?
Through its long-standing partnership with Super-Pharm, many Boots-branded products are staples in Israeli homes. Any shift in brand strategy, distribution, or product lines under Sycamore ownership could impact Israeli retail and consumer goods markets.
More strategically, Walgreens’ investments in healthtech platforms (VillageMD, CareCentrix, Summit Health) align with sectors where Israeli startups excel—telemedicine, pharmacy logistics, diagnostics. If these assets are restructured or sold, opportunities may open for Israeli players as partners, vendors, or even buyers.
